Eren Can Ekşi
Research Subjects
Eren Can Ekşi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Niklas Kempynck
Laboratory of Computational Biology, VIB Center for AI & Computational Biology (VIB.AI), Leuven, Belgium
7 shared publications - Stein Aerts
Laboratory of Computational Biology, VIB Center for AI & Computational Biology (VIB.AI), Leuven, Belgium
7 shared publications - Katina I. Spanier
Laboratory of Computational Biology, VIB Center for AI & Computational Biology, Leuven, Belgium
5 shared publications - Gert Hulselmans
Laboratory of Computational Biology, Department of Human Genetics, KU Leuven, Leuven, Belgium
4 shared publications - Lukas Mahieu
Laboratory of Computational Biology, VIB Center for AI & Computational Biology, Leuven, Belgium
4 shared publications - Seppe De Winter
Laboratory of Computational Biology, VIB Center for AI & Computational Biology (VIB.AI), Leuven, Belgium
4 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 2 April 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (5) , 946-959
CREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species
Sequence-based deep learning models have become the state of the art for analyzing the genomic regulatory code. Particularly for enhancers, these models excel at deciphering sequence grammar that underlies their activity. To enable end-to-end enhancer modeling and design, we developed a software package called CREsted ( cis -regulatory element sequence training, explanation and design). It combines preprocessing and analysis of single-cell assay for transposase-accessible chromatin using sequencing data, modeling chromatin accessibility from sequence, sequence design and downstream analysis to decipher enhancer grammar. We demonstrate CREsted’s functionality on a mouse cortex and a human peripheral blood mononuclear cell dataset. Additionally, we use CREsted to compare mesenchymal-like cancer cell states between tumor types, and we investigate different fine-tuning strategies of genomic foundation models within CREsted. Finally, we train a model on a zebrafish development atlas and use this to design and in vivo validate cell-type-specific enhancers. For varying datasets, we demonstrate that CREsted facilitates efficient training and analyses, enabling scrutinization of the enhancer logic and design of synthetic enhancers across tissues and species.
- 2 April 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (5) , 946-959
Top Cited PapersOpen AccessCREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species
Sequence-based deep learning models have become the state of the art for analyzing the genomic regulatory code. Particularly for enhancers, these models excel at deciphering sequence grammar that underlies their activity. To enable end-to-end enhancer modeling and design, we developed a software package called CREsted ( cis -regulatory element sequence training, explanation and design). It combines preprocessing and analysis of single-cell assay for transposase-accessible chromatin using sequencing data, modeling chromatin accessibility from sequence, sequence design and downstream analysis to decipher enhancer grammar. We demonstrate CREsted’s functionality on a mouse cortex and a human peripheral blood mononuclear cell dataset. Additionally, we use CREsted to compare mesenchymal-like cancer cell states between tumor types, and we investigate different fine-tuning strategies of genomic foundation models within CREsted. Finally, we train a model on a zebrafish development atlas and use this to design and in vivo validate cell-type-specific enhancers. For varying datasets, we demonstrate that CREsted facilitates efficient training and analyses, enabling scrutinization of the enhancer logic and design of synthetic enhancers across tissues and species.
- Open Access
- 22 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Evaluating single-cell ATAC-seq atlasing technologies using sequence-to-function modeling
Deciphering the cis-regulatory logic underlying cell type identity remains a key challenge in biology. Single-cell chromatin accessibility (scATAC-seq) atlases enable training of sequence-to-function (S2F) deep learning models to decode enhancer logic. Yet, optimal criteria for constructing training datasets, i.e., the number of cells and ATAC fragments, remain unclear. Moreover, the suitability of different scATAC-seq platforms for such models has not been systematically tested. We introduce HyDrop v2, an improved custom droplet scATAC-seq method, and perform the first benchmark of scATAC-seq platforms focusing on its capacity to train S2F models and its capacity to yield TF footprints in different species. We show that lower fragment counts can be compensated for by increased cell numbers. S2F models trained on custom or commercial data perform comparably in enhancer prediction, sequence explainability, and transcription factor footprinting. We demonstrate that integrating data from different scATAC-seq platforms enables large-scale, cost-efficient atlas construction for deep learning-based regulatory modeling.
- 22 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessEvaluating single-cell ATAC-seq atlasing technologies using sequence-to-function modeling
Deciphering the cis-regulatory logic underlying cell type identity remains a key challenge in biology. Single-cell chromatin accessibility (scATAC-seq) atlases enable training of sequence-to-function (S2F) deep learning models to decode enhancer logic. Yet, optimal criteria for constructing training datasets, i.e., the number of cells and ATAC fragments, remain unclear. Moreover, the suitability of different scATAC-seq platforms for such models has not been systematically tested. We introduce HyDrop v2, an improved custom droplet scATAC-seq method, and perform the first benchmark of scATAC-seq platforms focusing on its capacity to train S2F models and its capacity to yield TF footprints in different species. We show that lower fragment counts can be compensated for by increased cell numbers. S2F models trained on custom or commercial data perform comparably in enhancer prediction, sequence explainability, and transcription factor footprinting. We demonstrate that integrating data from different scATAC-seq platforms enables large-scale, cost-efficient atlas construction for deep learning-based regulatory modeling.
- Open Access
- 21 May 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (6) , 100879
Evaluating methods for the prediction of cell-type-specific enhancers in the mammalian cortex
- 21 May 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (6) , 100879
Open AccessEvaluating methods for the prediction of cell-type-specific enhancers in the mammalian cortex
- Open Access
HyDrop v2: Scalable atlas construction for training sequence-to-function models
Summary: Deciphering cis-regulatory logic underlying cell type identity is a fundamental question in biology. Single-cell chromatin accessibility (scATAC-seq) data has enabled training of sequence-to-function deep learning models allowing decoding of enhancer logic and design of synthetic enhancers. Training such models requires large amounts of high-quality training data across species, organs, development, aging, and disease. To facilitate the cost-effective generation of large scATAC-seq atlases for model training, we developed a new version of the open-source microfluidic system HyDrop with increased sensitivity and scale: HyDrop v2. We generated HyDrop v2 atlases for the mouse cortex and Drosophila embryo development and compared them to atlases generated on commercial platforms. HyDrop v2 data integrates seamlessly with commercially available chromatin accessibility methods (10x Genomics). Differentially accessible regions and motif enrichment across cell types are equivalent between HyDrop-v2 and 10x atlases. Sequence-to-function models trained on either atlas are comparable as well in terms of enhancer predictions, sequence explainability, and transcription factor footprinting. By offering accessible data generation, enhancer models trained on HyDrop-v2 and mixed atlases can contribute to unraveling cell-type specific regulatory elements in health and disease.
Open AccessHyDrop v2: Scalable atlas construction for training sequence-to-function models
Summary: Deciphering cis-regulatory logic underlying cell type identity is a fundamental question in biology. Single-cell chromatin accessibility (scATAC-seq) data has enabled training of sequence-to-function deep learning models allowing decoding of enhancer logic and design of synthetic enhancers. Training such models requires large amounts of high-quality training data across species, organs, development, aging, and disease. To facilitate the cost-effective generation of large scATAC-seq atlases for model training, we developed a new version of the open-source microfluidic system HyDrop with increased sensitivity and scale: HyDrop v2. We generated HyDrop v2 atlases for the mouse cortex and Drosophila embryo development and compared them to atlases generated on commercial platforms. HyDrop v2 data integrates seamlessly with commercially available chromatin accessibility methods (10x Genomics). Differentially accessible regions and motif enrichment across cell types are equivalent between HyDrop-v2 and 10x atlases. Sequence-to-function models trained on either atlas are comparable as well in terms of enhancer predictions, sequence explainability, and transcription factor footprinting. By offering accessible data generation, enhancer models trained on HyDrop-v2 and mixed atlases can contribute to unraveling cell-type specific regulatory elements in health and disease.
- Open Access
CREsted: modeling genomic and synthetic cell type-specific enhancers across tissues and species
Sequence-based deep learning models have become the state of the art for the analysis of the genomic regulatory code. Particularly for transcriptional enhancers, deep learning models excel at deciphering sequence features and grammar that underlie their spatiotemporal activity. To enable end-to-end enhancer modeling and design, we developed a software and modeling package, called CREsted. It combines preprocessing starting from single-cell ATAC-seq data; modeling with a choice of several architectures for training classification and regression models on either topics or pseudobulk peak heights; sequence design using multiple strategies; and downstream analysis through a collection of tools to locate transcription factor (TF) binding sites, infer the effect of a TF (activating or repressing) on enhancer accessibility, decipher enhancer grammar, and score gene loci. We demonstrate CREsted using a mouse cortex model that we validate using the BICCN collection of in vivo validated mouse brain enhancers. Classical enhancers in immune cells, including the IFNB1 enhanceosome are revisited using a PBMC model, and we assess the accuracy of TF binding site predictions with ChIP-seq. Additionally, we use CREsted to compare mesenchymal-like cancer cell states between tumor types; and we investigate different fine-tuning strategies of Borzoi within CREsted, comparing their performance and explainability with CREsted models trained from scratch. Finally, we train a CREsted model on a scATAC-seq atlas of zebrafish development and use this to design and in vivo validate cell type-specific synthetic enhancers in three tissues. For varying datasets, we demonstrate that CREsted facilitates efficient training and analyses, enabling scrutinization of the enhancer logic and design of synthetic enhancers across tissues and species. CREsted is available at https://crested.readthedocs.io .
Open AccessCREsted: modeling genomic and synthetic cell type-specific enhancers across tissues and species
Sequence-based deep learning models have become the state of the art for the analysis of the genomic regulatory code. Particularly for transcriptional enhancers, deep learning models excel at deciphering sequence features and grammar that underlie their spatiotemporal activity. To enable end-to-end enhancer modeling and design, we developed a software and modeling package, called CREsted. It combines preprocessing starting from single-cell ATAC-seq data; modeling with a choice of several architectures for training classification and regression models on either topics or pseudobulk peak heights; sequence design using multiple strategies; and downstream analysis through a collection of tools to locate transcription factor (TF) binding sites, infer the effect of a TF (activating or repressing) on enhancer accessibility, decipher enhancer grammar, and score gene loci. We demonstrate CREsted using a mouse cortex model that we validate using the BICCN collection of in vivo validated mouse brain enhancers. Classical enhancers in immune cells, including the IFNB1 enhanceosome are revisited using a PBMC model, and we assess the accuracy of TF binding site predictions with ChIP-seq. Additionally, we use CREsted to compare mesenchymal-like cancer cell states between tumor types; and we investigate different fine-tuning strategies of Borzoi within CREsted, comparing their performance and explainability with CREsted models trained from scratch. Finally, we train a CREsted model on a scATAC-seq atlas of zebrafish development and use this to design and in vivo validate cell type-specific synthetic enhancers in three tissues. For varying datasets, we demonstrate that CREsted facilitates efficient training and analyses, enabling scrutinization of the enhancer logic and design of synthetic enhancers across tissues and species. CREsted is available at https://crested.readthedocs.io .
- Open Access
Evaluating Methods for the Prediction of Cell Type-Specific Enhancers in the Mammalian Cortex
Summary: Identifying cell type-specific enhancers in the brain is critical to building genetic tools for investigating the mammalian brain. Computational methods for functional enhancer prediction have been proposed and validated in the fruit fly and not yet the mammalian brain. We organized the ‘Brain Initiative Cell Census Network (BICCN) Challenge: Predicting Functional Cell Type-Specific Enhancers from Cross-Species Multi-Omics’ to assess machine learning and feature-based methods designed to nominate enhancer DNA sequences to target cell types in the mouse cortex. Methods were evaluated based on in vivo validation data from hundreds of cortical cell type-specific enhancers that were previously packaged into individual AAV vectors and retro-orbitally injected into mice. We find that open chromatin was a key predictor of functional enhancers, and sequence models improved prediction of non-functional enhancers that can be deprioritized as opposed to pursued for in vivo testing. Sequence models also identified cell type-specific transcription factor codes that can guide designs of in silico enhancers. This community challenge establishes a benchmark for enhancer prioritization algorithms and reveals computational approaches and molecular information that are crucial for identifying functional enhancers in mammalian cortical cell types. The results of this challenge bring us closer to understanding the complex gene regulatory landscape of the mammalian cortex and to designing more efficient genetic tools to target cortical cell types.
Open AccessEvaluating Methods for the Prediction of Cell Type-Specific Enhancers in the Mammalian Cortex
Summary: Identifying cell type-specific enhancers in the brain is critical to building genetic tools for investigating the mammalian brain. Computational methods for functional enhancer prediction have been proposed and validated in the fruit fly and not yet the mammalian brain. We organized the ‘Brain Initiative Cell Census Network (BICCN) Challenge: Predicting Functional Cell Type-Specific Enhancers from Cross-Species Multi-Omics’ to assess machine learning and feature-based methods designed to nominate enhancer DNA sequences to target cell types in the mouse cortex. Methods were evaluated based on in vivo validation data from hundreds of cortical cell type-specific enhancers that were previously packaged into individual AAV vectors and retro-orbitally injected into mice. We find that open chromatin was a key predictor of functional enhancers, and sequence models improved prediction of non-functional enhancers that can be deprioritized as opposed to pursued for in vivo testing. Sequence models also identified cell type-specific transcription factor codes that can guide designs of in silico enhancers. This community challenge establishes a benchmark for enhancer prioritization algorithms and reveals computational approaches and molecular information that are crucial for identifying functional enhancers in mammalian cortical cell types. The results of this challenge bring us closer to understanding the complex gene regulatory landscape of the mammalian cortex and to designing more efficient genetic tools to target cortical cell types.
- Top Cited PapersOpen Access
- 12 December 2023
- Published by Springer Nature in Nature
- Vol. 626 (7997) , 212-220
Cell-type-directed design of synthetic enhancers
Transcriptional enhancers act as docking stations for combinations of transcription factors and thereby regulate spatiotemporal activation of their target genes1. It has been a long-standing goal in the field to decode the regulatory logic of an enhancer and to understand the details of how spatiotemporal gene expression is encoded in an enhancer sequence. Here we show that deep learning models2–6, can be used to efficiently design synthetic, cell-type-specific enhancers, starting from random sequences, and that this optimization process allows detailed tracing of enhancer features at single-nucleotide resolution. We evaluate the function of fully synthetic enhancers to specifically target Kenyon cells or glial cells in the fruit fly brain using transgenic animals. We further exploit enhancer design to create ‘dual-code’ enhancers that target two cell types and minimal enhancers smaller than 50 base pairs that are fully functional. By examining the state space searches towards local optima, we characterize enhancer codes through the strength, combination and arrangement of transcription factor activator and transcription factor repressor motifs. Finally, we apply the same strategies to successfully design human enhancers, which adhere to enhancer rules similar to those of Drosophila enhancers. Enhancer design guided by deep learning leads to better understanding of how enhancers work and shows that their code can be exploited to manipulate cell states.
- 12 December 2023
- Published by Springer Nature in Nature
- Vol. 626 (7997) , 212-220
Top Cited PapersOpen AccessCell-type-directed design of synthetic enhancers
Transcriptional enhancers act as docking stations for combinations of transcription factors and thereby regulate spatiotemporal activation of their target genes1. It has been a long-standing goal in the field to decode the regulatory logic of an enhancer and to understand the details of how spatiotemporal gene expression is encoded in an enhancer sequence. Here we show that deep learning models2–6, can be used to efficiently design synthetic, cell-type-specific enhancers, starting from random sequences, and that this optimization process allows detailed tracing of enhancer features at single-nucleotide resolution. We evaluate the function of fully synthetic enhancers to specifically target Kenyon cells or glial cells in the fruit fly brain using transgenic animals. We further exploit enhancer design to create ‘dual-code’ enhancers that target two cell types and minimal enhancers smaller than 50 base pairs that are fully functional. By examining the state space searches towards local optima, we characterize enhancer codes through the strength, combination and arrangement of transcription factor activator and transcription factor repressor motifs. Finally, we apply the same strategies to successfully design human enhancers, which adhere to enhancer rules similar to those of Drosophila enhancers. Enhancer design guided by deep learning leads to better understanding of how enhancers work and shows that their code can be exploited to manipulate cell states.